All News

Found 794,178 articles

• Phase 2 Study Finds That Jazz Pharmaceuticals, Inc.'s Xyrem(R) Relieves Pain And Improves Functioning In Patients Suffering From Fibromyalgia

  11/17/2005

• First Patients Enrolled In Three Breast Cancer Studies For Bioenvision's Modrenal(R)

  11/17/2005

• Jazz Pharmaceuticals, Inc. Release: Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain And Improves Functioning In Patients Suffering From Fibromyalgia

  11/17/2005

• Seattle Genetics, Inc. Initiates SGN-33 Clinical Trial

  11/17/2005

• Aegera Therapeutics's AEG35156 Phase 1 Oncology Trial Demonstrates Target Response In Cancer Patients

  11/17/2005

• Data From Phase I Trial Of Exelixis, Inc.' XL999 Establishing MTD Presented At Cancer Conference

  11/17/2005

• Allos Therapeutics, Inc. Release: Interim Phase 1 Data On RH1 Presented At AACR-NCI-EORTC Conference

  11/17/2005

• Vasogen's VP025 Prevents Detrimental Effects Of Beta-amyloid Exposure In Experimental Model Of Alzheimer's

  11/17/2005

• Human Genome Sciences, Inc. Reports Results Of Phase 1 Clinical Trials Of HGS-ETR2 In Patients With Advanced Solid Tumors

  11/17/2005

• Marshall Edwards, Inc. Release: Researchers Report That Phenoxodiol Produces Anti-Cancer Responses In Women With Cervical Cancer

  11/17/2005

• Sunesis Pharmaceuticals, Inc. Presents Promising Results Of Phase I Clinical Trial Of SNS-595 At The AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics

  11/17/2005

• GlycoGenesys, Inc. (Formerly SafeScience, Inc.) Initiates Additional Prestigious Medical Site For GCS-100 Phase I/II Multiple Myeloma Clinical Trial

  11/17/2005

• Angiotech Pharmaceuticals Announces Positive Interim Safety Data With Vascular Wrap(TM) At One year

  11/17/2005

• Marshall Edwards, Inc. Release: Phenoxodiol Delays Tumor Progression In Late-Stage Hormone Refractory Prostate Cancer

  11/17/2005

• Human Genome Sciences, Inc. Reports Interim Results Of Phase 1b Clinical Trials Of HGS-ETR1 In Combination With Chemotherapy In Patients With Advanced Solid Tumors

  11/17/2005

• DOR BioPharma, Inc. And Dow Pharmaceutical Sciences Complete Feasibility Study For Production Of BT-VACC

  11/17/2005

• Spectrum Pharmaceuticals, Inc. Presents Data At The AACR-NCI-EORTC Meeting That SPI-1620 Significantly Enhances The Anti-Tumor Efficacy Of Paclitaxel In Breast Tumor Model

  11/17/2005

• EntreMed, Inc. Presents ENMD-1198 Preclinical Data

  11/17/2005

• Hana Biosciences, Inc. Announces Positive In Vivo Preclinical Results Confirming Pharmacokinetics Of Zensana(TM)

  11/17/2005

• Point Therapeutics Presents Preclinical Anti-Tumor Data Of Talabostat In Combination With Pemetrexed And Erlotinib At AACR-EORTC-NCI Conference

  11/17/2005